We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.02B
AUM Growth
+$67.6M
Cap. Flow
+$92.8M
Cap. Flow %
9.11%
Top 10 Hldgs %
47.33%
Holding
173
New
45
Increased
25
Reduced
30
Closed
56

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$31.8M
2
FOLD
Amicus Therapeutics
FOLD
+$26.7M
3
ZBH icon
Zimmer Biomet
ZBH
+$24.4M
4
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$22.7M
5
INSM icon
Insmed
INSM
+$21.6M

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$17.8M
2
TSRO
TESARO, Inc.
TSRO
+$15.8M
3
EXAS
Exact Sciences
EXAS
+$12.7M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$10.4M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 82.29%
2 Miscellaneous 14.83%
3 Consumer Staples 1.81%
4 Financials 1.05%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHX
76
DELISTED
Athersys, Inc. Common Stock
ATHX
$1.08M 0.11%
24,074
-3,989
-14% -$196K
OXGN
77
DELISTED
OXIGENE INC COM
OXGN
$982K 0.1%
379,200
-120,800
-24% -$352K
ICAD
78
DELISTED
iCAD Inc
ICAD
$962K 0.09%
150,000
-25,000
-14% -$186K
CASC
79
DELISTED
Cascadian Therapeutics, Inc.
CASC
$949K 0.09%
48,797
-41,703
-46% -$736K
AKAO
80
DELISTED
Achaogen Inc
AKAO
$838K 0.08%
60,000
– –
EOCN
81
Eocene Ltd. Ordinary Shares
EOCN
$3.88M
$731K 0.07%
52
– –
VXRT
82
DELISTED
Vaxart
VXRT
$722K 0.07%
23,036
-14,691
-39% -$614K
PRPO icon
83
Precipio
PRPO
$48.6M
$687K 0.07%
+20
New +$695K
MBOT icon
84
Microbot Medical
MBOT
$96.7M
$551K 0.05%
168
– –
CLVS
85
DELISTED
Clovis Oncology, Inc.
CLVS
$452K 0.04%
10,917
-161,300
-94% -$8.31M
GNMX
86
DELISTED
Aevi Genomic Medicine Inc
GNMX
$428K 0.04%
55,073
-6,190
-10% -$43.7K
BLRX
87
BioLineRX
BLRX
$12.2M
$345K 0.03%
276
-22
-7% -$27.5K
HNT
88
DELISTED
HEALTH NET INC
HNT
$250K 0.02%
6,025
+750
+14% +$27.9K
UHS icon
89
Universal Health Services
UHS
$10.4B
$214K 0.02%
+2,236
New +$193K
ARNA
90
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$176K 0.02%
+3,000
New +$189K
RDNT icon
91
RadNet
RDNT
$6.07B
$152K 0.01%
+22,975
New +$132K
NUWE icon
92
Nuwellis
NUWE
$2.68M
– –
0
– –
ICLR icon
93
Icon
ICLR
$13.3B
$115K 0.01%
+2,440
New +$105K
EXAC
94
DELISTED
Exactech Inc
EXAC
$113K 0.01%
+4,464
New +$103K
ENSG icon
95
The Ensign Group
ENSG
$10.1B
$109K 0.01%
+7,502
New +$89.5K
CBPO
96
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$107K 0.01%
+2,400
New +$98K
MOH icon
97
Molina Healthcare
MOH
$10.8B
$106K 0.01%
+2,380
New +$96.5K
GTIV
98
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$106K 0.01%
+7,052
New +$79.5K
GTS
99
DELISTED
Triple-S Management Corporation
GTS
$105K 0.01%
+6,181
New +$99.7K
AFAM
100
DELISTED
Almost Family Inc
AFAM
$104K 0.01%
+4,708
New +$102K
2 3
4
5 6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Perceptive Advisors held 173 positions worth $1.02B, up 7.1% from $952M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $92.8M of net new capital in Q2 2014, opening 45 new positions and adding to 25 existing holdings. Its largest new stake was Zimmer Biomet: 249,775 shares worth $25.2M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 81% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $17.8M trimmed.

  • Perceptive Advisors's largest Q2 2014 buy was Zimmer Biomet: 249,775 shares worth $25.2M.
  • Perceptive Advisors added most to QUESTCOR PHARMA INC in Q2 2014, an estimated $31.8M increase.
  • Perceptive Advisors's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $17.8M.
  • Perceptive Advisors fully exited Endocyte, Inc. Common Stock in Q2 2014, selling an estimated $10.4M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $1.02B portfolio in Q2 2014.
  • Perceptive Advisors opened 45 new positions and closed 56 in Q2 2014.
  • Perceptive Advisors's portfolio value rose 7.1% quarter-over-quarter to $1.02B.

Based on Perceptive Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.